Macular Infarction Following Intravitreal Triamcinolone Injection for Treatment of Central Retinal Vein Occlusion. |
Jae Hoon Lee, Tai Kyong Kim, Young Chun Lee, Mee Yon Lee |
Department of Ophthalmology and Visual Science, The Catholic University of Korea Uijeongbu St. Mary's Hospital, The Catholic University of Korea School of Medicine, Uijeongbu, Korea. deenie@hanmail.net |
중심망막정맥폐쇄 환자에서 유리체강내 트리암시놀론 주입술 후 발생한 황반허혈 1예 |
이재훈⋅김태경⋅이영춘⋅이미연 |
가톨릭대학교 의과대학 가톨릭대학교 의정부성모병원 안과 및 시과학교실 |
Received: 15 May 2015 • Revised: 17 June 2015 • Accepted: 14 August 2015 |
Abstract |
PURPOSE To report a case of macular infarction following intravitreal triamcinolone injection for treatment of central retinal vein occlusion. CASE SUMMARY: A 75-year-old male visited our clinic for visual disturbance in his left eye and was diagnosed with macular infarction in his right eye. His medical history included type 2 diabetes, alcoholic liver cirrhosis, and hepatocellular carcinoma. After fundus examination, the patient was diagnosed with central vein occlusion with macular edema and intravitreal triamcinolone was administered to reduce edema. Within 1 week of treatment with the intravitreal injection, the patient experienced a significant decrease in visual acuity. Fluorescein angiogram showed an enlargement of the foveal avasacular zone, although optical coherence tomography (OCT) showed a decreased macular edema. Despite normalization of macular thickness on OCT and cessation of leakage on angiography, visual acuity remained at the same level during 2 months of follow-up. CONCLUSIONS: Intravitreal anti-vascular endothelial growth factor injection as well as intravitreal triamcinolone injection can cause macular ischemia which should be considered with the adopted treatment regimen for patients with ischemic risk factors. |
Key Words:
Central retinal vein occlusion;Ischemic maculopathy;Triamcinolone acetonide |